ArticleBMC cancer2025
A contrastive learning method integrating pathological prior information for effective differentiation of histological categories in lung squamous cell carcinoma.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvancements in digital pathology and computer technology have spurred artificial intelligence in histopathology, but the complexity of whole slide images (WSIs) poses challenges for manual annotation and traditional supervised learning.
methodsWe propose the Sample-Positive (SP) technique, which utilizes adjacent tissue morphology in WSIs to effectively sample positive examples. By integrating pathological prior information that reflects spatial adjacency of similar tissues with self-supervised learning (SSL) frameworks like SimCLR, MoCo-v3, and SinCLR, we developed an SSL method for WSI. We validated this approach on a dataset of 65 lung squamous cell carcinoma (LSCC) cases, covering four histological categories: necrosis, tumor, stroma, and epithelium. Performance was benchmarked against supervised models and original SSL frameworks using fine-tuning and linear evaluation, with metrics including accuracy (Acc), AUC, and F1 score.
resultsOur proposed SP technique outperformed baseline SSL methods in fine-tuning and linear evaluation tasks on the LSCC dataset. SPSimCLR and SPMoCo-v3 achieved the highest F1 scores, with SPSimCLR (0.9132) showing a 0.7% improvement over SimCLR (0.9067) and SPMoCo-v3 (0.9133) a 0.5% improvement over MoCo-v3 (0.9088) in fine-tuning, and SinCLR (0.9074) performs comparably to the original SSL methods. In linear evaluation, SPSimCLR (0.9082) improved F1 scores by 1.0% over SimCLR (0.8978), and SPMoCo-v3 (0.9060) improved by 1.2% over MoCo-v3 (0.8942), and SinCLR(0.9021) is surpass the original SSL methods. Ablation studies revealed that overlapping sampling slightly outperformed non-overlapping sampling, and that models trained on patches with single tissue types performed better than those trained on patches containing multiple tissue types.
conclusionsOverall, combining the SP technique with contrastive learning shows significant improvements in distinguishing histological categories in LSCC, making it effective for WSIs of non-diffuse cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.